Perrigo Company PLCの最新の1株当たり利益は$0.78で、$0.79の予想を殴打しない。
Perrigo Company PLC PRGOの前四半期の収益はどうでしたか?
Perrigo Company PLCの前四半期の収益は$0.78です。
Perrigo Company PLCの収益見積もりはいくらですか?
5人のウォール街のアナリストによると、Perrigo Company PLCの収益見積もりは$1.05Bから$970.69Mの範囲です。
Perrigo Company PLCの収益品質スコアはどれくらいですか?
Perrigo Company PLCの収益品質スコアはA/72.26388です。このスコアは、収益性、成長、キャッシュ生成と資本配分、レバレッジの4つの次元に基づいています。
Perrigo Company PLCはいつ収益を報告しますか?
Perrigo Company PLCの次の収益報告は2026-05-27に予定されています
Perrigo Company PLCの予想収益はいくらですか?
ウォール街のアナリストによると、Perrigo Company PLCの予想収益は$1.12Bです。
Perrigo Company PLCは収益予想を上回りましたか?
Perrigo Company PLCの最近の収益は$1.1Bで、予想を打ち勝たない。
主要データ
前終値
$11
始値
$10.85
当日レンジ
$10.72 - $11.32
52週レンジ
$9.23 - $28.44
取引高
2.6M
平均取引高
3.2M
配当利回り
10.78%
1株当たり利益(TTM)
-0.38
時価総額
$1.5B
PRGOとは何ですか?
Perrigo Co. Plc is a pure-play self-care company provider of consumer self-care products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. The company is headquartered in Dublin, Dublin. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. The company primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.